Clincosm LogoSign in Get a demo

stage iii nsclc

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

Not yet recruiting
  • Stage III NSCLC
  • Surgery
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Feb 21, 2023

Metastatic NSCLC, Stage III NSCLC Trial (inupadenant, Placebo, Carboplatin)

Recruiting
  • Metastatic NSCLC
  • Stage III NSCLC
  • Fayetteville, Arkansas
  • +16 more
Jan 25, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Non Small Cell Lung Cancer, Stage III NSCLC, EGFR Activating Mutation Trial in Hangzhou (Almonertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou Cancer hospital
Jan 8, 2021

Stage III NSCLC Trial in Seoul (standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001,

Withdrawn
  • Stage III NSCLC
  • standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001
  • PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001
  • Seoul, Korea, Republic of
    Department of Oncology, Yonsei University College of Medicine
Oct 14, 2020

Stage III NSCLC Trial in Amsterdam (drug, radiation, procedure)

Unknown status
  • Stage III NSCLC
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoek - Netherlands Cancer Institute
Feb 25, 2020